Article in Neuro-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Sylvia C KurzDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.ORCID 0000-0002-5247-5636
Anna McLeanDepartment of Neurosurgery, Jena University Hospital, Jena, Germany.ORCID 0000-0002-3146-4241
Mirjam RenovanzDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.ORCID 0000-0002-2824-3720
Julia SchwarzenbergerNovocure GmbH, Munich, Germany.
Lisa SevenichInstitute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.ORCID 0000-0002-6543-6273
Tadeja Urbanic PurkartDepartment of Neurology and Department of Radiology-Division of Neuroradiology, Vascular and Interventional Neuroradiology, Medical University of Graz, Graz, Austria.ORCID 0000-0001-5101-868X
Stephanie E CombsDepartment of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Ghazaleh TabatabaiDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.ORCID 0000-0002-3542-8782
Monika HegiLaboratory of Brain Tumour Biology and Genetics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-0855-6495
Martha NowosielskiDepartment of Neurology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-8068-315X
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative. · full record | OpenQuestion